Unexpected effect of weight-loss injections: eliminate knee pain
The experimental weight-loss drug Retatrutide has shown promising results in treating knee osteoarthritis. In two clinical trials, one in eight participants experienced complete pain relief, and two-thirds saw a 50% reduction in pain. The drug has not yet been approved by the FDA.
The experimental weight-loss drug Retatrutide has shown promising results in treating knee osteoarthritis. Results from two clinical trials published in The New England Journal of Medicine showed that the drug reduces pain and improves mobility in overweight individuals. The trials involved 1,019 adults with a body mass index of 27 or higher who did not have diabetes. One in eight participants experienced complete knee pain relief, and two-thirds saw a 50% reduction in pain. In the placebo group, this figure was 38%. The drug targets GLP-1, GIP, and glucagon hormone receptors. Retatrutide has not yet been approved by the FDA. Israeli orthopedist Dr. Alex Geftler noted that weight loss explains part of the effect, but the drug's direct anti-inflammatory action remains a hypothesis.
Unexpected effect of weight-loss injections: eliminate knee pain